CLOV vs PGNY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

CLOV

34.3
AI Score
VS
PGNY Wins

PGNY

64.4
AI Score

Investment Advisor Scores

CLOV

34score
Recommendation
SELL

PGNY

64score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CLOV PGNY Winner
Forward P/E 81.9672 13.1926 PGNY
PEG Ratio 0 0 Tie
Revenue Growth 55.6% 5.3% CLOV
Earnings Growth 0.0% 78.9% PGNY
Tradestie Score 34.3/100 64.4/100 PGNY
Profit Margin -0.7% 6.0% PGNY
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD PGNY

Relative Price Performance (Last 90 Days)

CLOV 1M: +0.0% · 3M: +1.2% PGNY 1M: -17.6% · 3M: +0.7%

Current Technical Phase

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $4.23

PGNY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 37.7 · Price: $25.86

Fundamentals Snapshot

Metric CLOV PGNY
Market Cap
Forward P/E 28.2 11.2
Trailing P/E 28.1
Revenue (TTM)
Revenue Growth 0.6% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.1%
EPS -0.05 0.94
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PGNY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.